Ping An Ventures was among the participants in China Diagnostics Medical Corporation's latest round, which was co-led by Legend Capital.

Multi-million-dollar investments by Anges will help Vasomune progress its peptide-based therapy for blood vessel-related diseases to the clinic.

BlueCross BlueShield Venture Partners returned to invest in the medical billing platform's series B round, six years after co-leading its series A.

The medical social media platform has added $146m to its coffers, though Tencent and China Electronics Corporation Data elected not to return at this stage.

Legal and General has participated in an $11.1m round for care services platform Care Sourcer that included Accelerated Digital Ventures.

The cosmetic surgery services platform has collected $50m in a Meitu-backed round, its existing backers including Tencent, Fosun and CHJ.

Athyrium Capital Management provided the capital for Debiopharm and Axa-backed breast cancer diagnostics system developer Agendia.

Biopharmaceutical company Liquidia Technologies, which counts PPD and Siemens as investors, floated in the middle of its range.

IP Group recorded a $24m loss in a period when the firm also restructured its business following the acquisition of Touchstone Innovations.

The UPMC Enterprises-backed mental health tool provider had raised more than $21m but is shuttering after failing to secure an acquisition.